Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Hess

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
American Journal of Public Health|April 9, 2020
Debunking Myths While Understanding LimitationsLisa M Hess, Katherine B Winfree, Catherine E Muehlenbein, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 5, 2018
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practicesA Scott Paulson, Lisa M Hess, Astra M Liepa, et al.
Sarcoma|April 8, 2020
Treatment Patterns and Healthcare Resource Utilization among Patients with Advanced or Metastatic Soft Tissue Sarcoma in US Community PracticesEric Nadler, Kathleen Aguilar, Chuck Wentworth, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Treatment heterogeneity and overall survival in patients with advanced/metastatic gastric or gastroesophageal junction adenocarcinoma in the United StatesJessica A Davis, Zhanglin Lin Cui, Madiha Ghias, et al.
Sarcoma|May 23, 2018
Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United StatesSantiago Zuluaga-Sanchez, Lisa M Hess, Sorrel E Wolowacz, et al.
Leukemia & Lymphoma|April 10, 2026
Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference studyChristine Michaels-Igbokwe, Hui Lu, Katherine B Winfree, et al.
Rare Tumors|May 13, 2022
Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trialBrian A Van Tine, Anders Krarup-Hansen, Lisa M Hess, et al.
Pragmatic and Observational Research|May 21, 2020
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United StatesLisa M Hess, Michael Grabner, Liya Wang, et al.
Cancers|August 14, 2025
Overall Survival Associated with Real-World Treatment Sequences in Patients with CLL/SLL in the United StatesJoanna M Rhodes, Naleen Raj Bhandari, Manoj Khanal, et al.
Systematic Reviews|September 18, 2014
Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancerAmy M DeLozier, Jacqueline Brown, Fanni Natanegara, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
American Journal of Public Health|April 9, 2020
Debunking Myths While Understanding LimitationsLisa M Hess, Katherine B Winfree, Catherine E Muehlenbein, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 5, 2018
Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practicesA Scott Paulson, Lisa M Hess, Astra M Liepa, et al.
Sarcoma|April 8, 2020
Treatment Patterns and Healthcare Resource Utilization among Patients with Advanced or Metastatic Soft Tissue Sarcoma in US Community PracticesEric Nadler, Kathleen Aguilar, Chuck Wentworth, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Treatment heterogeneity and overall survival in patients with advanced/metastatic gastric or gastroesophageal junction adenocarcinoma in the United StatesJessica A Davis, Zhanglin Lin Cui, Madiha Ghias, et al.
Sarcoma|May 23, 2018
Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United StatesSantiago Zuluaga-Sanchez, Lisa M Hess, Sorrel E Wolowacz, et al.
Leukemia & Lymphoma|April 10, 2026
Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference studyChristine Michaels-Igbokwe, Hui Lu, Katherine B Winfree, et al.
Rare Tumors|May 13, 2022
Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trialBrian A Van Tine, Anders Krarup-Hansen, Lisa M Hess, et al.
Pragmatic and Observational Research|May 21, 2020
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United StatesLisa M Hess, Michael Grabner, Liya Wang, et al.
Cancers|August 14, 2025
Overall Survival Associated with Real-World Treatment Sequences in Patients with CLL/SLL in the United StatesJoanna M Rhodes, Naleen Raj Bhandari, Manoj Khanal, et al.
Systematic Reviews|September 18, 2014
Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancerAmy M DeLozier, Jacqueline Brown, Fanni Natanegara, et al.
Pageof 11